To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC90035 | Rp-101075 |
Metabolite of ozanimod, exhibiting a similar specificity profile as ozanimod at the S1P receptor family in vitro and pharmacodynamic profile in vivo
More description
|
|
| DC90034 | Rl2578 |
Negative control for Borussertib, being >1000 fold less potent in vitro than Borussertib
More description
|
|
| DC90032 | Remodelin-yne |
Clickable Remodelin analog
More description
|
|
| DC90031 | Rac-ac-ro5203548 |
Prodrug of RO5203548, a selective agonist of the trace amine-associated receptor 1 (TAAR1)
More description
|
|
| DC90030 | Qpx7831 Sodium |
Novel Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728
More description
|
|
| DC90029 | Pu-h54-iso |
An isomer of PU-H54, a novel Grp94- and Hsp90-selective inhibitor
More description
|
|
| DC90028 | Pro-dmocptl-13 |
Prodrug of DMOCPTL
More description
|
|
| DC90027 | Primordazine Nc-6364997 |
Negative control for Primordazine A and Primordazine B
More description
|
|
| DC90026 | Pptn-nc |
Negative control for PPTN
More description
|
|
| DC90025 | Pim-in-72 |
Less active enantiomer of LGH447, acting as a selective weak pan-PIM inhibitor (IC 50 (µM): PIM1 0.095; PIM2 0.522; PIM3 0.369) in comparision with LGH447 (IC 50 (µM): PIM1 0.001; PIM2 0.002; PIM3 0.002)
More description
|
|
| DC90024 | Phip-d |
Deuterated internal standard for PhIP
More description
|
|
| DC90023 | Pfi-6n |
Negative control for PFI-6
More description
|
|
| DC90022 | Pfi-653-n |
Negative control for PFI-653
More description
|
|
| DC90021 | Pf-06465603 |
Metabolite of PF-04691502, a highly potent and selective ATP competitive kinase inhibitor of class 1 PI3Ks and mTOR
More description
|
|
| DC90020 | Pafuramidine Maleate |
Pro-drug of furamidine, acting as antiprotozoal/antifungal agent
More description
|
|
| DC90019 | Pa-9-3d |
Novel PA-9 analog, acting as an antagonist of the PAC1 receptor, showing improved antagonistic activities than PA-9
More description
|
|
| DC90018 | Oncrasin-266 |
Prodrug of antitumor agent oncrasin-72, with improved stability, pharmacokinetics, and safety
More description
|
|
| DC90017 | Og-881 |
Novel potent and highly selective KDM1A chemoprobe, exhibiting a selectivity profile similar to the parent compound ORY-1001
More description
|
|
| DC90016 | O-desmethyl Vu0467485 |
PET Precursor of VU0467485
More description
|
|
| DC90015 | Nvs-mllt-c |
Negative control for NVS-MLLT-1
More description
|
|
| DC90014 | Nvs-malt1-c |
|
|
| DC90013 | Nvs-bptf-c |
Nagative control for NVS-BPTF-1
More description
|
|
| DC90012 | Nuc041 |
Prodrug of NUC013, a novel DNA methytransferase inhibitor
More description
|
|
| DC90011 | Nc-vhl |
Negative control for Homer
More description
|
|
| DC90010 | Ncgc-959 |
The negative control compound for ML323
More description
|
|
| DC90009 | Mu-1656 |
Novel Highly Selective Inhibitor of Methyltransferase DOT1L, being more metabolically stable and significantly less toxic in vivo than pinometostat
More description
|
|
| DC90008 | Mspbtz169 |
Novel potent antitubercular agent, inhibiting decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1), displaying better aqueous solubility and metabolic stability than PBTZ169
More description
|
|
| DC90007 | Msc-0516 |
Negative control for MDC-4381
More description
|
|
| DC90006 | Ms4370 |
Negative control for MS4322
More description
|
|
| DC90005 | Ms154n |
Negative control for MS154
More description
|
|